These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2659117
21. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies. Nakamura H, Hirayama F, Tatsumi Y, Tani Y, Kubota Y, Kanakura Y, Oguma S, Ueda T, Shibata H, Masaoka T. Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454 [Abstract] [Full Text] [Related]
22. [Monoclonal antibody and purging]. Ueda R, Morishima Y. Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016 [No Abstract] [Full Text] [Related]
23. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC. Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720 [Abstract] [Full Text] [Related]
24. Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complement. Tong AW, Dalton WS, Tsuruo T, Fay JW, Stone MJ. Prog Clin Biol Res; 1990 Mar; 333():155-64. PubMed ID: 2308979 [Abstract] [Full Text] [Related]
25. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission. Abrahm JL, Gerson SL, Hoxie JA, Tannenbaum SH, Cassileth PA, Cooper RA. Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922 [Abstract] [Full Text] [Related]
26. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells. Ball ED, Kadushin JM, Schacter B, Fanger MW. J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897 [Abstract] [Full Text] [Related]
27. Autologous bone marrow transplantation for acute myeloid leukemia following in vitro treatment with neuraminidase and monoclonal antibodies. Ball ED, Vredenburgh JJ, Mills LE, Cornwell GG, Schwarz L, Howell AL, Troy K. Bone Marrow Transplant; 1990 Oct; 6(4):277-80. PubMed ID: 1982228 [Abstract] [Full Text] [Related]
28. Monoclonal antibodies and magnetic microspheres for the depletion of leukaemic cells from bone marrow harvested for autologous transplantation. Kemshead JT, Treleaven J, Heath L, Meara AO, Gee A, Ugelstad J. Bone Marrow Transplant; 1987 Aug; 2(2):133-9. PubMed ID: 3332162 [Abstract] [Full Text] [Related]
29. Human monoclonal antibodies reactive with human myelomonocytic leukemia cells. Posner MR, Santos DJ, Elboim HS, Tumber MB, Frackelton AR. Cancer Res; 1989 Apr 01; 49(7):1665-70. PubMed ID: 2924315 [Abstract] [Full Text] [Related]
30. Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells. Martens AC, Johnson RJ, Kaizer H, Hagenbeek A. Exp Hematol; 1984 Sep 01; 12(8):667-71. PubMed ID: 6386506 [Abstract] [Full Text] [Related]
31. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates. Ueda M, Joshi ID, Dan M, Uberti JP, Chou TH, Sensenbrenner LL, Lum LG. Transplantation; 1993 Aug 01; 56(2):351-6. PubMed ID: 8356589 [Abstract] [Full Text] [Related]
32. Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging. Janssen WE, Lee C, Gross S, Gee AP. Exp Hematol; 1989 Mar 01; 17(3):252-7. PubMed ID: 2917623 [Abstract] [Full Text] [Related]
33. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Bast RC, De Fabritiis P, Lipton J, Gelber R, Maver C, Nadler L, Sallan S, Ritz J. Cancer Res; 1985 Feb 01; 45(2):499-503. PubMed ID: 3967224 [Abstract] [Full Text] [Related]
34. Efficacy of bone marrow purging in AML using monoclonal antibodies and complement. Mills LE, Ball ED, Howell AL, Cornwell GG, Thompson L, Spruce W, Miller WE, McMillan R. Prog Clin Biol Res; 1990 Feb 01; 333():165-70. PubMed ID: 2308980 [No Abstract] [Full Text] [Related]
35. Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation. Zola H, Potter A, Neoh SH, Juttner CA, Haylock DN, Rice AM, Favaloro EJ, Kabral A, Bradstock KF. Bone Marrow Transplant; 1987 Feb 01; 1(3):297-301. PubMed ID: 3332140 [Abstract] [Full Text] [Related]
36. Depletion of T-lymphocytes in donor marrow with pan-T monoclonal antibodies and complement for prevention of acute graft-versus-host disease: a pilot study on 29 patients. Herve P. J Natl Cancer Inst; 1986 Jun 01; 76(6):1311-6. PubMed ID: 3520074 [Abstract] [Full Text] [Related]
38. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies. Ball ED, Mills LE, Coughlin CT, Beck JR, Cornwell GG. Blood; 1986 Dec 01; 68(6):1311-5. PubMed ID: 3535927 [Abstract] [Full Text] [Related]
39. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Betticher DC, Huxol H, Müller R, Speck B, Nissen C. Exp Hematol; 1993 Nov 01; 21(12):1517-21. PubMed ID: 8405233 [Abstract] [Full Text] [Related]
40. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement. Morishima Y, Miyamura K, Kojima S, Ueda R, Morishita Y, Sao H, Tanimoto M, Ohno R, Sobue R, Hirano M. Bone Marrow Transplant; 1993 Apr 01; 11(4):255-9. PubMed ID: 7683550 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]